The Role of Telemedicine in Providing Appropriate Cannabis Care
Telemedicine offers a vital opportunity to improve patient access, convenience, and quality of cannabis care, especially in underserved or rural areas where specialist care may be limited.
The Association of Cannabinoid Specialists (ACS) supports the responsible use of telemedicine platforms for medical cannabis evaluations and ongoing management, provided that all clinical encounters adhere to the highest standards of thoroughness, professional ethics, and informed consent.
Telemedicine Reduces Barriers to Cannabinoid Medicine
When properly implemented, telemedicine enhances treatment continuity and reduces barriers such as travel time and inconvenience, which often prevent patients from obtaining timely care.
It enables clinicians to conduct comprehensive medical histories, assess patient symptoms, and provide detailed counseling on the risks, benefits, dosing strategies, and potential side effects of cannabis treatment.
Telemedicine also supports ongoing monitoring and dose adjustments to optimize therapeutic outcomes.
Clinical Standards and Meeting Standards of Care
However, ensuring quality care in telemedicine cannabis services hinges on strict adherence to clinical standards. These include prioritizing patient well-being above financial or other conflicts of interest, thorough documentation of medical reasoning, and inclusion of informed consent discussions covering risks and benefits.
Telemedicine providers must assess when virtual evaluations are appropriate and when in-person examinations are necessary to meet the standard of care.
Oversight and Compliance by Boards of Registration
The appropriate oversight and enforcement of these standards rest with Boards of Registration for Medicine, Nursing, and Pharmacy. These Boards play a critical role in maintaining public trust by investigating and addressing provider misconduct or substandard care in any practice setting, including telemedicine.
ACS urges Boards to actively enforce compliance with ethical and professional guidelines in cannabis medicine, focusing especially on protecting patients through enforcement of informed consent and quality care standards.
Expanding Access to Cannabis Care Through Telemedicine
Restricting telemedicine itself is not an effective or suitable tactic for targeting unscrupulous providers. Instead, regulatory focus should be on ensuring that practitioners delivering care—whether remotely or in person—are appropriately educated, accountable, and transparent in their care decisions.
The Association of Cannabinoid Specialists stands ready to support Boards of Registration in these efforts to safeguard patient health while expanding access to ethically delivered cannabis care through telemedicine.